xi's moments
Home | Africa

Senegalese President Macky Sall inoculated with Chinese COVID-19 vaccine

Xinhua | Updated: 2021-02-26 10:06

Senegalese President Macky Sall receives his first dose of COVID-19 vaccine manufactured by China's Sinopharm, in presidential palace on Feb 25, 2021. [Photo/Xinhua]

DAKAR - Senegalese President Macky Sall received his first dose of COVID-19 vaccine manufactured by China's Sinopharm, in presidential palace here on Thursday.

Head of the Economic, Social and Environmental Council Idrissa Seck, and some members of the government and presidential office staffers were also vaccinated.

Addressing the nation after his vaccination, the Senegalese president said that he wanted to show that all people over the age of 60 should be able to be vaccinated.

He said that he and members of the government were vaccinated to set an example.

He also reassured his people about the reliability of the vaccines, calling on the Senegalese to be vaccinated and to ignore rumors about the vaccines.

President Sall stressed that his government has put a lot of efforts to acquire the vaccines.

According to latest updates of Senegalese Ministry of Health and Social Action published on Thursday, as of Wednesday, a total of 4,776 people were already vaccinated against COVID-19 with Sinopharm's vaccine.

Senegalese health authorities on Tuesday launched the national vaccination campaign against COVID-19 with the 200,000 doses of the vaccine manufactured by Sinopharm.

For this first phase of vaccination campaign, the priority targets are front-line health care workers, people over the age of 60, and people living with underlying health conditions.

Senegal reported its first confirmed case of COVID-19 on March 2, 2020. Since then, the country has recorded 33,741 positive cases, including 28,112 recoveries and 852 deaths.

Global Edition
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349